Scarica l'app Stockscreener
18.84
2.45%
0.45
Dopo l'orario di chiusura:
18.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$18.39
Aprire:
$18.41
Volume 24 ore:
1.12M
Relative Volume:
0.71
Capitalizzazione di mercato:
$932.82M
Reddito:
$230.59M
Utile/perdita netta:
$-96.37M
Rapporto P/E:
-9.6265
EPS:
-1.9571
Flusso di cassa netto:
$-39.54M
1 W Prestazione:
+2.06%
1M Prestazione:
+17.02%
6M Prestazione:
-31.99%
1 anno Prestazione:
+8.21%
Intervallo 1D:
$18.08
$18.85
Intervallo di 1 settimana:
$17.03
$18.91
Portata 52W:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
18.84 | 932.82M | 230.59M | -96.37M | -39.54M | -1.9571 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-03 | Iniziato | Wedbush | Neutral |
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
The Chart That Says You're Right on STAAR Surgical - AOL.com
Broadwood group (NASDAQ: STAA) reports 32.6% STAAR Surgical stake - Stock Titan
Midday Stock Roundup: Veritone Down 5% After Delaying Q4, FY Earnings - Orange County Business Journal
Refractive Vision Correction Market is expected to hit US$ 8.53 - openPR.com
Director at STAAR Surgical (STAA) receives 7,524 long-dated options - Stock Titan
Director at STAAR Surgical (STAA) receives grant of 7,524 stock options - Stock Titan
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com Nigeria
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com Nigeria
Staar Surgical taps Amico Group as Middle East distributor - Arab News PK
STAAR Surgical Co. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Makes New $4.81 Million Investment in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical net loss hits USD 18.3M in Q4 2025 - Medical Buyer
STAA: Wells Fargo Lowers Price Target by 47.97% on Staar Surgica - GuruFocus
Wells Fargo & Company Cuts STAAR Surgical (NASDAQ:STAA) Price Target to $16.00 - MarketBeat
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives - simplywall.st
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results - VisionMonday.com
Canaccord reiterates Hold on STAAR Surgical stock, $22 target By Investing.com - Investing.com Canada
Needham maintains Hold on STAAR Surgical stock after Q4 miss - Investing.com Nigeria
Staar Surgical Posts Q4 Loss After Rejecting Alcon Deal - Medical Device and Diagnostic industry
STAAR Surgical Q4 2025 Earnings Report: Revenue Growth & Analyst OutlookNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Weak Earnings - MarketBeat
Staar Surgical Q4 2025 Earnings: Revenue and Earnings Miss EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAA Analyst Rating Update: Stifel Lowers Price Target | STAA St - GuruFocus
Stifel Nicolaus Issues Pessimistic Forecast for STAAR Surgical (NASDAQ:STAA) Stock Price - MarketBeat
A Glimpse Into The Expert Outlook On Staar Surgical Through 7 Analysts - Benzinga
STAAR Surgical Company Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% - The Globe and Mail
Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
STAAR Surgical Q4 2025 Earnings Call Transcript - MarketBeat
STAAR Surgical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips - Investing.com Nigeria
Staar Surgical co-CEOs address shareholders, poor Q4 earnings - MassDevice
STAAR Surgical names interim co-CEOs, targets 2026 growth - Investing.com Australia
STAA Reports Lower Q4 Revenue Amidst Inventory Adjustments and M - GuruFocus
STAAR Surgical stock plunges 12% on unexpected Q4 loss By Investing.com - Investing.com Canada
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates - Yahoo Finance UK
STAAR Surgical Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (STAA) STAAR Surgical Posts Q4 Loss of $0.37, vs. FactSet Est EPS of $0.04 - marketscreener.com
STAAR Surgical names interim co-CEOs, targets 2026 growth By Investing.com - Investing.com India
STAAR Surgical stock plunges 12% on unexpected Q4 loss - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Issues Earnings Results - MarketBeat
Staar Surgical: Q4 Earnings Snapshot - Bitget
Staar Surgical reports Q4 EPS 0c, consensus 17c - TipRanks
Earnings Breakdown: Staar Surgical Q4 - Benzinga
STAAR Surgical Company (STAA) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):